---
title: "COHEN ABRAHAM E — Ownership Dossier"
canonical: https://whiteintel.dev/entity/04ed3972-9c71-5599-8983-e46508f20200
json: https://whiteintel.dev/api/public/dossier/04ed3972-9c71-5599-8983-e46508f20200
identifier: sec:0001255789
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# COHEN ABRAHAM E

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001255789`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/04ed3972-9c71-5599-8983-e46508f20200  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/04ed3972-9c71-5599-8983-e46508f20200  

## Ownership & control

### Holdings / subsidiaries

- **NEUROBIOLOGICAL TECHNOLOGIES INC /CA/** (director) — https://whiteintel.dev/entity/c0511b15-3b31-5861-8bad-81f02319f12f
- **Lineage Cell Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/3d0dce36-5722-5eb1-b928-ce69417f4b69
- **MANNKIND CORP** (director) — https://whiteintel.dev/entity/cba4bf58-8c50-5faf-8c1f-003fc13e37a8

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **COHEN ABRAHAM E**. Human view: https://whiteintel.dev/entity/04ed3972-9c71-5599-8983-e46508f20200 · Structured JSON: https://whiteintel.dev/api/public/dossier/04ed3972-9c71-5599-8983-e46508f20200._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._